+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

North America In-vitro Colorectal Cancer Screening Tests Market Report and Forecast 2024-2032 - Product Thumbnail Image

North America In-vitro Colorectal Cancer Screening Tests Market Report and Forecast 2024-2032

  • Report
  • June 2024
  • 120 Pages
  • North America
From
Latin America In-vitro Colorectal Cancer Screening Tests Market Report and Forecast 2024-2032 - Product Thumbnail Image

Latin America In-vitro Colorectal Cancer Screening Tests Market Report and Forecast 2024-2032

  • Report
  • June 2024
  • 140 Pages
  • Latin America
From
Europe In-Vitro Colorectal Cancer Screening Tests Market Report and Forecast 2024-2032 - Product Thumbnail Image

Europe In-Vitro Colorectal Cancer Screening Tests Market Report and Forecast 2024-2032

  • Report
  • June 2024
  • 140 Pages
  • Europe
From
In-Vitro Colorectal Cancer Screening Tests Market Report and Forecast 2024-2032 - Product Thumbnail Image

In-Vitro Colorectal Cancer Screening Tests Market Report and Forecast 2024-2032

  • Report
  • April 2024
  • 140 Pages
  • Global
From
Small Cell Lung Cancer (SCLC) Market Report and Forecast 2024-2032 - Product Thumbnail Image

Small Cell Lung Cancer (SCLC) Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Pancreatic Cancer: Eight-Market Drug Forecast - Product Thumbnail Image

Pancreatic Cancer: Eight-Market Drug Forecast

  • Report
  • July 2025
  • Global
From
Non-small Cell Lung Cancer: Seven-Market Drug Forecast and Market Analysis - Product Thumbnail Image

Non-small Cell Lung Cancer: Seven-Market Drug Forecast and Market Analysis

  • Report
  • May 2025
  • 87 Pages
  • Global
From
B-Cell Non-Hodgkin's Lymphoma: Epidemiology Forecast to 2033 - Product Thumbnail Image

B-Cell Non-Hodgkin's Lymphoma: Epidemiology Forecast to 2033

  • Report
  • March 2025
  • 55 Pages
  • Global
From
Colorectal Cancer - Eight-Market Drug Forecast and Market Analysis - Product Thumbnail Image

Colorectal Cancer - Eight-Market Drug Forecast and Market Analysis

  • Report
  • December 2023
  • 146 Pages
  • Global
From
Glioblastoma Multiforme (GBM) - Competitive Landscape - Product Thumbnail Image

Glioblastoma Multiforme (GBM) - Competitive Landscape

  • Report
  • December 2023
  • 75 Pages
  • Global
From
Anal Cancer (AC) - Competitive Landscape - Product Thumbnail Image

Anal Cancer (AC) - Competitive Landscape

  • Report
  • December 2023
  • 77 Pages
  • Global
From
Artificial Pancreas Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies - Product Thumbnail Image

Artificial Pancreas Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

  • Report
  • November 2023
  • 121 Pages
  • Global
From
Cervical Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update - Product Thumbnail Image

Cervical Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  • Report
  • November 2023
  • 1129 Pages
  • Global
From
Immuno-Oncology - Thematic Intelligence - Product Thumbnail Image

Immuno-Oncology - Thematic Intelligence

  • Report
  • May 2023
  • 169 Pages
  • Global
From
Canada Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 - Product Thumbnail Image

Canada Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030

  • Report
  • May 2023
  • 15 Pages
  • Canada
From
Australia Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 - Product Thumbnail Image

Australia Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030

  • Report
  • May 2023
  • 15 Pages
  • Australia
From
India Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 - Product Thumbnail Image

India Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030

  • Report
  • May 2023
  • 15 Pages
  • India
From
Italy Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 - Product Thumbnail Image

Italy Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030

  • Report
  • May 2023
  • 15 Pages
  • Italy
From
Germany Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 - Product Thumbnail Image

Germany Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030

  • Report
  • May 2023
  • 15 Pages
  • Germany
From
Myelofibrosis Epidemiology Analysis and Forecast, 2021-2031 - Product Thumbnail Image

Myelofibrosis Epidemiology Analysis and Forecast, 2021-2031

  • Report
  • July 2022
  • 56 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more